MedPath

Clinical Study on the Treatment of Spleen Deficiency Syndrome's Atopic Dermatitis with Yunpi Huashi Qingfei Decoction and Its Regulation on Bitter Taste Receptor

Early Phase 1
Recruiting
Conditions
Atopic dermatitis
Registration Number
ITMCTR2024000143
Lead Sponsor
onghua Hospital Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1) Conforming to the Western medicine Williams diagnostic criteria.
2) Conforming to the diagnostic criteria of spleen deficiency syndrome in Traditional Chinese Medicine.
3) The severity of skin lesions belongs to mild to moderate (ESAI = 21 points).
4) Patients' age is above 8 years old and below 60 years old, regardless of gender and ethnicity.
5) Giving informed consent to this clinical project (if the patient is a minor, the consent of the patient and the legal guardian is required), and cooperating with the follow-up and researchers.

Exclusion Criteria

1) Patients with severe internal medicine or surgical diseases;
2) Females who are pregnant or preparing for pregnancy and those in the lactation period;
3) Patients with a history of mental disorders;
4) Patients who have used TCS, TCI and other drugs for treating skin diseases within the recent two weeks;
5) Patients who have used immunosuppressants, antibiotics and biological agents for treatment within the recent two weeks;
6) Patients allergic to any component of the experimental drug.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.